A.P. Pharma, Inc. APPA Company Overview  A.P. Pharma,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
A.P. Pharma, Inc. APPA Company Overview 

A.P. Pharma, Inc. APPA Current Price and Quotes
Last Price 0.46
Previous Close 0.445 Open 0.47
Daily Range 0.48 - 0.45 52wk Range 0.89 - 0.28
Volume 1,221,415 Dividend N/A
Average Vol (3m) 817,507 Yield N/A

APPA Stock Message Board http://investorshangout.com/search?q=APPA&...mp;yt1=Go!

Last Updated: Wednesday, October 30, 2013 02:21:46 AM

A.P. Pharma, Inc. APPA
Company Information

123 Saginaw Drive
Redwood City, CA 94063

Website: http://www.appharma.com
Phone: 650-366-2626

A.P. Pharma, Inc. APPA
A.P. Pharma, Inc. APPA
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000818033
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Barry D. Quart CEO
Robert Rosen President
Stephen R. Davis COO, EVP
Edie DeVine IR
Company Directors

Not Available
Company Notes

Note = Company delisted from NASDAQ on 04/01/11
Formerly=Advanced Polymer Systems, Inc. until 5-01
Service Providers

Auditor/Accountant
Odenberg, Ullakko, Muranishi & Co. LLP
Legal Counsel
Not Available
Investor Relations Firm
Not Available

A.P. Pharma, Inc. APPA
APPA Security Details

Share Structure

Market Value1 $141,205,841 a/o Oct 29, 2013
Shares Outstanding 306,969,219 a/o Jul 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.01
Shareholders

Shareholders of Record 143 a/o Mar 01, 2013
Security Notes

New Issue=8-87 2,000,000 shs at $7 by Allen & Company, Inc
Delisted from NASDAQ on 04/01/11
Capital Change=shs decreased by 1 for 4 split. Pay date=05/25/2007.
Short Selling Data

Short Interest 175,470 (-2.51%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Computershare Investor Services LLC

A.P. Pharma, Inc. APPA Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - 646 1,301 1,261
Cost of Revenue - - - -
Gross Profit - 646 1,301 1,261
Operating Expenses

Research and Development 15,045 8,207 7,264 7,796
Sales, General and Admin. 8,786 3,501 3,971 3,707
Non-Recurring Items - - - -
Other - - - -
Operating Income (23,831) (11,062) (9,934) (10,242)
Income From Continuing Operations

Add'l Income/Expense Items - - 2,740 (5)
Earnings Before Interest and Tax (23,831) (11,062) (7,194) (10,218)
Interest Expense 599 373 2 -
Earnings Before Tax (24,430) (11,435) (7,196) (10,218)
Income Tax - - - (122)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (24,430) (11,435) (7,196) (10,096)
Non Recurring Events

Discontinued Operations 1,082 (379) (150) 68
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (23,348) (11,814) (7,346) (10,028)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (23,348) (11,814) (7,346) (10,028)

A.P. Pharma, Inc. APPA Recent News

Aug 8, 2013 A.P. Pharma, Inc. Announces Planned Name Change to "Heron Therapeutics, Inc." and Application to List on NASDAQ Capital Market
Aug 8, 2013 A.P. Pharma Announces Second Quarter 2013 Financial Results and Highlights Recent Corporate Progress


APPA A.P. Pharma, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=APPA&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/APPA/quote
Stock Chart http://www.otcmarkets.com/stock/APPA/chart
Company Info http://www.otcmarkets.com/stock/APPA/company-info
Recent News http://www.otcmarkets.com/stock/APPA/news
Financials http://www.otcmarkets.com/stock/APPA/financials
Filings and Disclosure http://www.otcmarkets.com/stock/APPA/filings
Short Sales http://www.otcmarkets.com/stock/APPA/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/APPA/insider-transactions
Research Reports http://www.otcmarkets.com/stock/APPA/research
Summary http://finance.yahoo.com/q?s=APPA
Historical Prices http://finance.yahoo.com/q/hp?s=APPA+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=APPA
Basic Chart http://finance.yahoo.com/q/bc?s=APPA+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=APPA+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=APPA+Headlines
Press Releases http://finance.yahoo.com/q/p?s=APPA+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=APPA+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=APPA+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=APPA+Industry
Major Holders http://finance.yahoo.com/q/mh?s=APPA+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=APPA+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=APPA+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=APPA
Balance Sheet http://finance.yahoo.com/q/bs?s=APPA
Cash Flow http://finance.yahoo.com/q/cf?s=APPA+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/APPA
Market Watch http://www.marketwatch.com/investing/stock/APPA
Bloomberg http://www.bloomberg.com/quote/APPA:US
Morningstar http://quotes.morningstar.com/stock/s?t=APPA
Bussinessweek http://investing.businessweek.com/research/st...icker=APPA
Barchart http://www.barchart.com/quotes/stocks/APPA
OTC Short Report http://otcshortreport.com/index.php?index=APPA
Investopedia http://www.investopedia.com/markets/stocks/APPA/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading